secwatch.observer — SEC 8-K summary
======================================

Issuer:     HYPERION DEFI, INC. (HYPD)
CIK:        0001682639
Form:       8-K
Filed at:   2025-03-20T23:59:59+00:00
Accession:  0001104659-25-026120
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Eyenovia enters non-binding LOI for reverse merger with Betaliq; EYEN holders to own ~16.3%
--------------------------------------------------------------------------------

- Reverse merger: Betaliq stockholders would own ~83.7% of combined company; Eyenovia holders ~16.3% on fully diluted basis.
- Betaliq valued at ~$77M, Eyenovia at ~$15M (net cash zero at close); Eyenovia had $2.1M cash as of Dec 31, 2024.
- Exclusivity period ends May 16, 2025; conditions include due diligence, definitive agreement, board approvals, and financing.
- Combined company would continue marketing Eyenovia's FDA-approved products and leverage EyeSol+Optejet technologies.
- Eyenovia expects to change name to Betaliq and update trading symbol; no assurance deal will close.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1682639/000110465925026120/0001104659-25-026120-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1682639/000110465925026120/tm259898d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-026120

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer